• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物辅助常规疗法治疗三阴性乳腺癌及其免疫调节活性。

Natural-Product-Derived Adjunctive Treatments to Conventional Therapy and Their Immunoregulatory Activities in Triple-Negative Breast Cancer.

机构信息

Institute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China.

State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China.

出版信息

Molecules. 2023 Aug 1;28(15):5804. doi: 10.3390/molecules28155804.

DOI:10.3390/molecules28155804
PMID:37570775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10421415/
Abstract

Triple-negative breast cancer (TNBC) is an invasive and persistent subtype of breast cancer that is likely to be resistant to conventional treatments. The rise in immunotherapy has created new modalities to treat cancer, but due to high costs and unreliable efficacy, adjunctive and complementary treatments have sparked interest in enhancing the efficacy of currently available treatments. Natural products, which are bioactive compounds derived from natural sources, have historically been used to treat or ameliorate inflammatory diseases and symptoms. As TNBC patients have shown little to no response to immunotherapy, the potential of natural products as candidates for adjuvant immunotherapy is being explored, as well as their immunomodulatory effects on cancer. Due to the complexity of TNBC and the ever-changing tumor microenvironment, there are challenges in determining the feasibility of using natural products to enhance the efficacy or counteract the toxicity of conventional treatments. In view of technological advances in molecular docking, pharmaceutical networking, and new drug delivery systems, natural products show promise as potential candidates in adjunctive therapy. In this article, we summarize the mechanisms of action of selected natural-product-based bioactive compounds and analyze their roles and applications in combination treatments and immune regulation.

摘要

三阴性乳腺癌(TNBC)是一种侵袭性和持续性的乳腺癌亚型,可能对常规治疗产生抗药性。免疫疗法的兴起为癌症治疗创造了新的方法,但由于成本高和疗效不可靠,辅助和补充治疗激发了人们提高现有治疗方法疗效的兴趣。天然产物是从天然来源中提取的生物活性化合物,历史上一直被用于治疗或缓解炎症性疾病和症状。由于 TNBC 患者对免疫疗法几乎没有反应,因此正在探索天然产物作为辅助免疫疗法候选物的潜力,以及它们对癌症的免疫调节作用。由于 TNBC 的复杂性和不断变化的肿瘤微环境,确定使用天然产物来提高疗效或抵消常规治疗毒性的可行性存在挑战。鉴于分子对接、药物网络和新型药物输送系统等技术的进步,天然产物作为辅助治疗的潜在候选物具有广阔的前景。在本文中,我们总结了选定的基于天然产物的生物活性化合物的作用机制,并分析了它们在联合治疗和免疫调节中的作用和应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d612/10421415/539d85a6c91e/molecules-28-05804-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d612/10421415/539d85a6c91e/molecules-28-05804-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d612/10421415/539d85a6c91e/molecules-28-05804-g001.jpg

相似文献

1
Natural-Product-Derived Adjunctive Treatments to Conventional Therapy and Their Immunoregulatory Activities in Triple-Negative Breast Cancer.天然产物辅助常规疗法治疗三阴性乳腺癌及其免疫调节活性。
Molecules. 2023 Aug 1;28(15):5804. doi: 10.3390/molecules28155804.
2
Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.三阴性乳腺癌的免疫治疗:现存挑战与振奋前景。
Drug Resist Updat. 2017 May;32:1-15. doi: 10.1016/j.drup.2017.07.002. Epub 2017 Aug 19.
3
Current Advancements of Plant-Derived Agents for Triple-Negative Breast Cancer Therapy through Deregulating Cancer Cell Functions and Reprogramming Tumor Microenvironment.植物源制剂通过调控癌细胞功能和重编程肿瘤微环境治疗三阴性乳腺癌的最新进展。
Int J Mol Sci. 2021 Dec 17;22(24):13571. doi: 10.3390/ijms222413571.
4
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies.三阴性乳腺癌的组织蛋白酶 D 靶向抗体免疫治疗。
J Immunother Cancer. 2019 Feb 4;7(1):29. doi: 10.1186/s40425-019-0498-z.
5
Photosensitive small extracellular vesicles regulate the immune microenvironment of triple negative breast cancer.光敏性小细胞外囊泡调节三阴性乳腺癌的免疫微环境。
Acta Biomater. 2023 Sep 1;167:534-550. doi: 10.1016/j.actbio.2023.06.004. Epub 2023 Jun 10.
6
Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer.免疫疗法在三阴性乳腺癌患者中的应用进展与困境。
Expert Opin Investig Drugs. 2022 Jun;31(6):567-591. doi: 10.1080/13543784.2022.2049232. Epub 2022 Mar 9.
7
The prognostic marker KRT81 is involved in suppressing CD8 + T cells and predicts immunotherapy response for triple-negative breast cancer.预后标志物 KRT81 可抑制 CD8+T 细胞,并预测三阴性乳腺癌的免疫治疗反应。
Cancer Biol Ther. 2024 Dec 31;25(1):2355705. doi: 10.1080/15384047.2024.2355705. Epub 2024 May 22.
8
Development and verification of a novel immunogenic cell death-related signature for predicting the prognosis and immune infiltration in triple-negative breast cancer.一种新型免疫原性细胞死亡相关特征的开发与验证,用于预测三阴性乳腺癌的预后和免疫浸润。
Cancer Rep (Hoboken). 2024 Mar;7(3):e2007. doi: 10.1002/cnr2.2007.
9
A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer.一种与肿瘤微环境相关的新型模型预测三阴性乳腺癌的预后和免疫治疗。
Clin Exp Med. 2023 Nov;23(7):3867-3881. doi: 10.1007/s10238-023-01090-5. Epub 2023 May 23.
10
Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.维替泊芬光动力疗法联合 5-氮杂-2′-脱氧胞苷增强三阴性乳腺癌的抗肿瘤免疫反应。
Front Immunol. 2023 Nov 7;14:1188087. doi: 10.3389/fimmu.2023.1188087. eCollection 2023.

引用本文的文献

1
A comprehensive review on anti-inflammatory plants: a mechanistic insight through preclinical and clinical studies.抗炎植物综述:基于临床前和临床研究的机制洞察
Inflammopharmacology. 2025 Jun 4. doi: 10.1007/s10787-025-01764-4.
2
Curcumenol inhibits malignant progression and promotes ferroptosis via the SLC7A11/NF‑κB/TGF‑β pathway in triple‑negative breast cancer.莪术烯醇通过SLC7A11/NF-κB/TGF-β途径抑制三阴性乳腺癌的恶性进展并促进铁死亡。
Int J Mol Med. 2025 Jul;56(1). doi: 10.3892/ijmm.2025.5552. Epub 2025 May 16.
3
A Comprehensive Review on Biofilms in Otorhinolaryngology: Understanding the Pathogenesis, Diagnosis, and Treatment Strategies.

本文引用的文献

1
Development of actein derivatives as potent anti-triple negative breast cancer agents.阿替生衍生物的开发作为有效的三阴性乳腺癌治疗药物。
Bioorg Med Chem Lett. 2023 Jun 1;89:129307. doi: 10.1016/j.bmcl.2023.129307. Epub 2023 Apr 28.
2
In vitro synergistic effect of hesperidin and doxorubicin downregulates epithelial-mesenchymal transition in highly metastatic breast cancer cells.橙皮苷与阿霉素的体外协同作用下调高转移性乳腺癌细胞中的上皮-间质转化
J Egypt Natl Canc Inst. 2023 Mar 27;35(1):6. doi: 10.1186/s43046-023-00166-3.
3
Paeonol inhibits melanoma growth by targeting PD1 through upregulation of miR-139-5p.
耳鼻咽喉科生物膜综合综述:了解发病机制、诊断及治疗策略
Cureus. 2024 Apr 4;16(4):e57634. doi: 10.7759/cureus.57634. eCollection 2024 Apr.
4
Unraveling the anti-breast cancer activity of Cimicifugae rhizoma using biological network pathways and molecular dynamics simulation.利用生物网络途径和分子动力学模拟揭示升麻的抗乳腺癌活性
Mol Divers. 2025 Feb;29(1):241-254. doi: 10.1007/s11030-024-10847-3. Epub 2024 Apr 13.
丹皮酚通过上调miR-139-5p靶向PD1抑制黑色素瘤生长。
Biochem Biophys Res Commun. 2023 May 14;656:86-96. doi: 10.1016/j.bbrc.2023.03.005. Epub 2023 Mar 5.
4
Ginsenoside Rg3 liposomes regulate tumor microenvironment for the treatment of triple negative breast cancer.人参皂苷Rg3脂质体通过调节肿瘤微环境来治疗三阴性乳腺癌。
Drug Dev Ind Pharm. 2023 Jan;49(1):139-148. doi: 10.1080/03639045.2023.2188078. Epub 2023 Mar 13.
5
Clinical efficacy of tetrandrine in artificial stone-associated silicosis: A retrospective cohort study.粉防己碱治疗人工结石相关性矽肺的临床疗效:一项回顾性队列研究。
Front Med (Lausanne). 2023 Feb 17;10:1107967. doi: 10.3389/fmed.2023.1107967. eCollection 2023.
6
NK cells are never alone: crosstalk and communication in tumour microenvironments.自然杀伤细胞从不孤单:肿瘤微环境中的串扰和通讯。
Mol Cancer. 2023 Feb 16;22(1):34. doi: 10.1186/s12943-023-01737-7.
7
Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment.乳腺癌各亚型中的肿瘤浸润淋巴细胞:生物标志物评估的当前问题
Cancers (Basel). 2023 Jan 26;15(3):767. doi: 10.3390/cancers15030767.
8
Tetrandrine Inhibits Cancer Stem Cell Characteristics and Epithelial to Mesenchymal Transition in Triple-Negative Breast Cancer via SOD1/ROS Signaling Pathway.粉防己碱通过SOD1/ROS信号通路抑制三阴性乳腺癌中的癌症干细胞特性和上皮-间质转化
Am J Chin Med. 2023;51(2):425-444. doi: 10.1142/S0192415X23500222. Epub 2023 Jan 20.
9
Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti-cancer evaluation of peritumoral hydrogel injection combined with PD-L1 antibody.基于壳聚糖衍生物的具有渗透增强作用的人参皂苷Rg3纳米颗粒通过热敏水凝胶包裹阿霉素,并对瘤周水凝胶注射联合PD-L1抗体进行抗癌评估。
Biomater Res. 2022 Dec 9;26(1):77. doi: 10.1186/s40824-022-00329-8.
10
Polysaccharides influence human health microbiota-dependent and -independent pathways.多糖通过微生物群依赖和非依赖途径影响人类健康。
Front Nutr. 2022 Nov 9;9:1030063. doi: 10.3389/fnut.2022.1030063. eCollection 2022.